Pricing Log in Create free account

Belite Bio, Inc. Sponsored ADR (BLTE) vs Praxis Precision Medicines, Inc. (PRAX)

Belite Bio, Inc. Sponsored ADR and Praxis Precision Medicines, Inc. are both Biotechnology companies. Praxis Precision Medicines, Inc. is the larger, with a market value of $6.9B against $6.2B — 1.1× the size. Across the 9 metrics below, Belite Bio, Inc. Sponsored ADR leads on 6 and Praxis Precision Medicines, Inc. on 3.

Valuation

Metric BLTE PRAX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 823.42 9.71
P/B 7.45 5.25 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 734.73 9.21
Earnings yield (1.91%) (5.35%) (33.15%)
Free cash flow yield (1.16%) (4.35%) (25.50%)

Profitability

Metric BLTE PRAX Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (38.86%) (56.36%)
Return on assets (21.60%) (36.80%) (48.04%)
Return on invested capital (9.55%) (40.58%) 0.00%

Growth

Metric BLTE PRAX Biotechnology median
Revenue growth (TTM) — 249.53% 6.02%
EPS growth (last fiscal year) (95.76%) (32.03%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLTE PRAX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 33.56 15.73 4.72
Net debt to EBITDA 5.88 1.82 0.96

Dividend

Metric BLTE PRAX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BLTE PRAX Biotechnology median
Market cap 6.15b 6.93b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack